Company intelligence / Profile preview
Rosetta Life Care
Mumbai, Maharashtra, India
- Ownership
- Private
- Development stage
- Other
01
Overview
Rosetta Life Care markets finished pharmaceutical and nutraceutical formulations in Asia and the Middle East, as well as proprietary food supplements in Europe. Their peptide-based product EnzoImmune Max is marketed for immune support and claims scientific proof of antiviral efficacy; however, there is no evidence of clinical trial results in the public domain.
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyInfectious DiseasesNeurology
- Modalities
- BiologicPeptidesSmall moleculeNutraceutical
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Rosetta Life Care.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rosetta Life Care.